Also, with the evidence that loss of mTOR resulted in an activation of ERK [57], the combination of decursin and doxorubicin upregulated the phosphorylation of ERK in the three multiple myeloma cells, indicating that ERK activation is associated with inhibition of mTOR/S6K1 signaling. The gene discussed is RPS6KB1; the disease is AL amyloidosis.